| I N TR ODU C TI ON
Feline morbillivirus (FeMV), family Paramyxoviridae, was originally discovered in Hong Kong in 2012. Sequencing and phylogenetic analyses confirmed that FeMV is a distinct virus species. 1 Paramyxoviruses are enveloped, single-stranded, negative RNA viruses, which have been previously identified in a wide variety of vertebrate hosts. 2 Upon discovery, the presence of FeMV was associated with histopathologically confirmed tubulointerstitial nephritis (TIN) in stray cats 1 and the virus has since been detected in the urine of cats in Japan, Germany, Italy, USA, South America, and Turkey. [3] [4] [5] [6] [7] [8] [9] [10] Furthermore, there is an association between paramyxoviruses and renal pathology in a range of species, including humans, 11 rats, 12 bats, 13 and squirrels. 14 Tubulointerstitial nephritis is the most common lesion in cats with chronic kidney disease (CKD) 15 and FeMV RNA is more prevalent in renal tissues of cats with TIN compared with blood and urine samples from the same animals. 5 CKD is a common condition of older cats, with a 4% prevalence in UK 1st opinion practice. 17 Current treatment protocols have limited efficacy and therefore, CKD is an important cause of morbidity and mortality in geriatric cats. 18 The etiopathogenesis of TIN in cats with CKD is unclear at present, and determination of risk factors for CKD could help to further clarify the inciting factors that lead to TIN and CKD in cats, which could in turn lead to better preventative strategies, such as vaccination.
The primary aims of our study were to (1) identify if paramyxoviruses (including FeMV) are present in the urine of cats in the UK, (2) to develop a serological assay to establish if there is evidence of exposure of UK cats to FeMV, and (3) to evaluate if a relationship exists between the presence of azotemic CKD and the detection of serum anti-FeMV antibodies, the urinary excretion of paramyxoviruses (including FeMV) or both.
| M A TE RI A L S A ND M E TH ODS

| Sample selection
A free-of-charge screening programme at three UK 1st-opinion To be included in the study, cats were aged 8 years old with no significant systemic disease (eg, diabetes mellitus or hyperthyroidism).
Exclusion criteria included recent or ongoing treatment with corticosteroids, diuretics, or angiotensin-converting enzyme inhibitors, and recent or concurrent IV fluid treatment at the time of sampling. Samples were excluded from the study if TT4 >40 nmol/L, if urine samples were older than 3 days at the time of analysis, if there was evidence of significant systemic illness on complete blood count or biochemistry or if there was evidence of lower urinary tract inflammation on urinalysis (pyuria, bacteriuria, and hematuria).
Excess urine was stored at 2808C until batch RNA isolation. Renal azotemia was diagnosed by documentation of an increased concentration of serum creatinine in conjunction with reduced urine concentrating ability. 20 Cats were assigned to either the azotemic CKD group (defined as serum creatinine concentration >1.7 mg/dL or 153 mmol/L (the upper limit of our laboratory reference interval) and concurrent USG < 1.035)
or the nonazotemic group. Table 1 summarizes the results for the cat population studied (79 cats in total). Urine RT-PCR was performed in 16 azotemic cats (designated A1-A16) and 24 nonazotemic cats (designated S1-S11; and H1-H13). Serology was performed in 72 cats in total (designated A1-A16; S1-S8; H1-H9; H14-H52). 33/40 (82%) cats had concurrent serology and urine RT-PCR performed.
A power calculation performed based on the prevalence of FeMV in cats with and without TIN 1 indicated that the study needed a minimum of 14 cats per group to be 80% powered to find significant differences between the groups.
| RT-PCR and nested RT-PCR amplification
RNA isolation was performed using the QIAamp Viral RNA Mini Kit (Qiagen, Manchester) following the manufacturer's instructions.
We used a broadly reactive PCR assay reported to detect all known paramyxoviruses. 2 The primer targets correspond to highly conserved regions of the genome (L protein) and can detect 25 reference viruses from the paramyxovirus family. The published method was slightly modified by using random hexamers to generate the cDNA as we found this resulted in greater and more consistent yields of PCR product. cDNA synthesis was performed using Superscript III (Invitrogen, Carlsbad, California) following the manufacturer's instructions. 10 ml of the cDNA reaction was used as input for the 1st round of seminested PCR using 1 lM forward (PAR-F1) and reverse primers (PAR-R) subjected to 40 cycles of amplification (948C for 15 seconds, 488C ramping to 508C for 30 seconds, 728C for 30 seconds) and a final extension at 728C for 7 minutes. The 2nd amplification in the seminested PCR used 2 mL of template from the 1st amplification under the same conditions as the 1st except the forward primer PAR-F2 replaced PAR-F1.
The final PCR products were visualized by ultraviolet light after electrophoresis on a 2% agarose gel containing 0.5 mg/mL ethidium bromide.
| DNA sequencing
Bands of the appropriate size (500 bp) were excised from the gel and DNA was extracted using the Purelink Quick Gel Extraction Kit (Invitrogen, Carlsbad, California) before being sent for Sanger sequencing using the primers PAR-F2 and PAR-R (Source BioScience, Cambridge, UK).
The sequences were compared with the complete nonredundant nucleotide database using BLASTn (http://blast.ncbi.nlm.nih.gov).
| Sequence alignment
Multiple sequence alignment and phylogeny representation of the amplified region of the L gene were performed using the MUSCLE, GBlocks, PhyML, and TreeDyn tools as implemented in the "One-click" mode of Phyogeny.fr. 21 The alignment was displayed using MView. 22 
| N protein PCR amplification
The N protein is highly conserved with >90% nucleotide sequence identity amongst the FeMVs but distinct from other morbilliviruses. 4 The N protein has previously been assessed by indirect immunofluorescence assay for seroprevalence studies of FeMV where a seroprevalence of 21% was identified. 16 Amplification of the N gene of FeMV from urine sample RNA was performed using nested PCR. cDNA was produced as described above (except for using primer The secondary nested PCR procedure was carried out as above except for using pASG-IBA144 insertion primers (N_pASG_N_termF RT-PCR was performed on 16 azotemic cats (A1-A16) and 24 non-azotemic cats (S1-S11, H1-H13). serology was performed on 72 cats (A1-A16, S1-S8, H1-H9, H14-H52). FPV, feline paramyxovirus; FeMV, feline morbillivirus; A, azotemic; NA, nonazotemic; SP, strong positive; POS, positive; WP, weak positive; NEG, negative; NT, not tested; HB, high background (therefore, could not be scored definitively).
(Invitrogen) and subsequently transferred into E. coli BL21 DE3. The complete sequence of the N-gene and associated affinity tags for the chosen clone was subsequently verified.
| Expression and partial purification of FeMV N protein
One milliliter of overnight starter culture was added to 10 mL LB Amp 100 medium and incubated at 378C shaking at 225 rpm until the 
| SDS PAGE and Western blotting (WB)
SDS PAGE was performed using a 8% resolving gel and 4.5% stacking gel under reducing conditions. After semidry transfer to a nitrocellulose membrane and blocking [5% nonfat-dried milk powder dissolved in 19 mM Tris pH 7.4. 137 mM NaCl, 2.7 mM KCl, 0.1% Tween20 (TBST)], the blot was probed for His-tagged N protein expression and enrichment using 1:500 mouse anti-6xHis antibody (Merck Millipore/ cat #05-949) followed by a 1:2000 dilution of horseradish peroxidase conjugated goat anti-mouse IgG secondary antibody (Sigma-Aldrich, cat #A3673).
To screen multiple cat sera simultaneously for reactivity to the Nprotein, 50 mL of Ni-NTA bead-enriched N protein was loaded onto a full gel-width well, electrophoresed, transferred, and blocked as before. A primary assay validation of the WB assay was performed using sera from all 5 cats that tested positive for FeMV in urine via PCR, 1
cat that was positive for non-FeMV and 5 FeMV RNA negative cats to test for reactivity to the 58 kDa doublet (Figure 1 ).
| Statistical analysis
Comparisons between groups were made using Fisher's exact test and 
| Detection and characterization of paramyxovirus RNA in urine samples
Morbillivirus L gene sequences were detected by RT-PCR in 5 out of 40 of the urine samples ( Table 1) . Analysis of the aligned sequences ( Figure 2) showed that they were all highly similar (Table 2 ) and all 5
were phylogenetically most closely related to the USA strain FeMV-US1 (accession number KR014147) with the Hong Kong strains 761U
and 776U (JQ411014 and JQ411015, respectively) being the next most closely related. Samples A1, S2, and H1 clustered as a single group with FeMV-US1. S1 and H3 mapped as two further distinct isolates. The N gene coding region cloned from sample S1 also most closely matched these three isolates (see below). Three distinct nonFeMV paramyxoviruses were also detected (samples S6, S9 and H10) that were most closely related to strain FPV-MSi-2014 from Germany (accession number KP 159805). Of these, H10 and S6 formed a distinct subgroup. S9 was the most closely related to FPV-MSi-2014.
| Correlation of paramyxovirus RNA in urine and health status
FeMV RNA detection was not significantly different between azotemic CKD and non-azotemic groups (1/16 versus 4/24 respectively; P 5 .36. Table 1 ). Although the non-FeMV paramyxoviruses were only detected in the nonazotemic group, this difference from the azotemic group was not significant (3/24 versus 0/16, respectively; P 5 .15; Table 3 ).
To assess the effect of urine concentration on the likelihood of detecting FeMV and non FeMV paramyxovirus, the proportion of cats with USG >1.035 that were positive for FeMV and non-FeMV paramyxovirus in their urine was compared with that of cats with USG <1.035.
FeMV detection was not significantly different between cats in the USG
<1.035 and USG >1.035 group (2/12 versus 2/12; P 5 1.0). Non-FeMV paramyxovirus detection was also not significantly different between USG <1.035 and USG >1.035 group (1/12 versus 2/12; P 5 .55).
| N Protein expression
The N sequence from cat S1 (a nonazotemic cat testing positive for FeMV RNA) was cloned and sequenced. It was most closely related to the 761U and US1 strains (1538 and 1537 out of 1557 nucleotide identity; 514 and 515 out of 518 amino acid identity, respectively). WB analysis using antibody to the C-terminal 6xHis-tag introduced during cloning showed a doublet band straddling the 58 kDa prestained 
| D ISC USSION
Our study identified RNA from FeMV and non-FeMV paramyxoviruses in the urine of cats, thus confirming the presence of these viruses in cats in the United Kingdom. In addition, a high percentage of UK cats had detectable serum antibodies to FeMV (31% or 64% depending on whether the weak positives were included), indicating that a substantial proportion of UK cats have evidence of exposure to this/or a related virus. However, we did not detect an association between urinary excretion of these viruses, or the presence of serum anti-FeMV antibodies, and the presence of azotemic CKD. This is in contrast with the previously documented association between FeMV and the presence of histopathologically confirmed TIN (the most common lesion in cats with CKD), 1 but is in agreement with a subsequent study from Japan which found no association between TIN and FeMV infection. 16 In both of these previous studies, FeMV status was determined by a combination of RT-PCR, serology and immunohistochemistry.
Recently, Sieg et al 6 reported an association between urinary excretion of FeMV and CKD in cats, which is in contrast to the findings of our study. However, it should be noted that the Sieg study did not use a homogenous group of biochemically confirmed azotemic cats, as the CKD group also included cats diagnosed with feline lower urinary tract disease (FLUTD), nephritis, hematuria, urolithiasis, cystitis, urostase, chronic kidney failure, chronic nephropathy, proteinuria, and bacteriuria. In contrast, our study excluded cats with evidence of other etiologies such as lower urinary tract inflammation and only included cats with biochemical evidence of renal azotemia. The seropositive rate of UK cats was higher (31%-64%) than has been reported in previous studies (21%-28%). 1, 4, 16, 23 All of the previous studies evaluated the seroprevalence in Japanese cat populations, therefore it appears that a greater number of UK cats have been exposed to the virus. This could reflect increased proportion of outdoor cats given that a greater proportion of cats with street access had detectable FeMV in urine in a recent study. 10 It has also been reported that there can be antigenic cross-reactivity between FeMV and canine distemper virus, 4 and 10% of serum samples from cats had neutralizing antibodies against CDV, 24 therefore it is also possible that the higher seropositive rate in our cats could partly be explained by the presence of anti-CDV antibodies rather than anti-FeMV in some cats.
If the weak positive samples were excluded, the 31% prevalence is more consistent with the results from Japan. The overall prevalence of FeMV in the urine of UK cats was 13%, which was similar to the prevalence documented in Hong Kong (12%) 7 and Japan (6%-23%) [3] [4] [5] 16, 25 but higher than that documented in Turkey (3%). Future studies investigating the seroprevalence of FeMV in cats with and without CKD when using this novel biomarker could be warranted.
There are a several limitations of our study. We have not confirmed the presence of live virus by viral isolation studies, however previous studies have identified live virus from all RNA positive cats. 1, 4 Furthermore qRT-PCR has been reported to be more sensitive than conventional PCR for detecting FeMV RNA in urine samples. 25 However, we repeated our assays using the qRT-PCR method but did not identify any additional cats with urinary FeMV that were not detected by our seminested PCR assay (data not shown 27 Furthermore, it would have been useful to perform complete viral genome sequencing to allow for further studies evaluating the genetic diversity of morbillivirus compared to other strains detected worldwide. However, detecting multiple differences in the highly conserved L gene region suggests that these viruses were genetically distinct.
In conclusion, our study reports the detection of RNA from FeMV 
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